US7955832B2ExpiredUtilityPatentIndex 68
Composition useful for protein fragment complementation assays (PCA) using fragments of E. coli/TEM-1 β-lactamase
Est. expiryFeb 2, 2018(expired)· nominal 20-yr term from priority
C12N 15/1055G01N 33/502C07K 14/43595G01N 33/68G01N 33/6845G01N 2333/986G01N 33/531G01N 33/5008G01N 33/58
68
PatentIndex Score
5
Cited by
2
References
5
Claims
Abstract
The present invention describes an assay method comprising: (A) generating (1) at least a first fragment of a reporter molecule linked to a first interacting domain and at least a second fragment of a reporter molecule linked to a second interacting domain, or (2) nucleic acid molecules that code for (A)(1) and subsequently allowing said nucleic acid molecules to produce their coded products; then, (B) allowing interaction of said domains; and (C) detecting reconstituted reporter molecule activity, where said reporter molecule can react with a penicillin- or a cephalosporin-class substrate.
Claims
exact text as granted — not AI-modified1. A composition comprising:
(A) a first compound comprising a first fragment of an interacting domain linked to a first fragment of a β-lactamase reporter enzyme that catalyses the hydrolysis of the amide bond of β-lactam rings in penicillin or cephalosporin compounds; and
(B) a second compound comprising a second fragment of an interacting domain linked to a second fragment of said β-lactamase reporter enzyme wherein components (A) and (B) upon complementation results in reconstitution of β-lactamase activity.
2. A composition comprising a compound which comprises a fragment of an interacting domain linked to a first fragment of a β-lactamase reporter enzyme that catalyses the hydrolysis of the amide bond of β-lactam rings in penicillin or cephalosporin compounds upon binding to a second complementary fragment of the β-lactamase reporter enzyme.
3. A composition according to claim 2 or 1 where said interacting domain is derived from a leucine zipper or from a rapamycin-inducible interacting protein.
4. A composition according to claim 2 or 1 where said interacting domain is derived from a GCN 4 leucine zipper or from FKBP/FRB.
5. A composition according to claim 2 or 1 wherein at least one of said compounds has a flexible linker joining its reporter molecule fragment to its associated interacting domain.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.